John D. Baxter

24.7k total citations · 3 hit papers
265 papers, 19.4k citations indexed

About

John D. Baxter is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, John D. Baxter has authored 265 papers receiving a total of 19.4k indexed citations (citations by other indexed papers that have themselves been cited), including 128 papers in Molecular Biology, 102 papers in Endocrinology, Diabetes and Metabolism and 97 papers in Genetics. Recurrent topics in John D. Baxter's work include Estrogen and related hormone effects (85 papers), Thyroid Disorders and Treatments (52 papers) and HIV Research and Treatment (34 papers). John D. Baxter is often cited by papers focused on Estrogen and related hormone effects (85 papers), Thyroid Disorders and Treatments (52 papers) and HIV Research and Treatment (34 papers). John D. Baxter collaborates with scholars based in United States, Brazil and Canada. John D. Baxter's co-authors include Gordon M. Tomkins, Brian L. West, Guy Rousseau, Joseph Martial, James W. Apriletti, Paul Webb, Michael Karin, Peter J. Kushner, Robert J. Fletterick and Ralff C.J. Ribeiro and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

John D. Baxter

260 papers receiving 18.2k citations

Hit Papers

A Method for Isolation of Intact, Translationally Active ... 1972 2026 1990 2008 1983 1995 1972 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John D. Baxter United States 78 9.0k 6.7k 6.1k 1.7k 1.5k 265 19.4k
John A. Wagner United States 63 5.9k 0.7× 2.1k 0.3× 1.1k 0.2× 1.3k 0.8× 1.9k 1.3× 250 13.8k
Jack R. Wands United States 86 10.6k 1.2× 2.6k 0.4× 1.5k 0.2× 1.3k 0.8× 5.1k 3.4× 445 29.0k
Marc K. Hellerstein United States 73 5.3k 0.6× 3.2k 0.5× 1.1k 0.2× 1.5k 0.9× 5.9k 4.0× 297 19.1k
Pierre Rustin France 77 16.6k 1.8× 1.6k 0.2× 1.1k 0.2× 888 0.5× 2.5k 1.7× 302 23.3k
Mike Mueckler United States 55 7.9k 0.9× 1.4k 0.2× 1.1k 0.2× 559 0.3× 2.7k 1.8× 113 12.3k
Masahiko Negishi United States 96 15.7k 1.7× 4.5k 0.7× 5.7k 0.9× 435 0.3× 2.8k 1.9× 514 33.2k
Monty Krieger United States 78 11.0k 1.2× 3.4k 0.5× 1.4k 0.2× 390 0.2× 1.9k 1.3× 185 24.2k
David D. Moore United States 92 11.8k 1.3× 5.0k 0.7× 6.5k 1.1× 351 0.2× 2.9k 2.0× 286 27.8k
Mary‐Ellen Harper Canada 67 8.7k 1.0× 709 0.1× 1.6k 0.3× 987 0.6× 7.6k 5.2× 243 18.6k
Nancy A. Thornberry United States 58 18.3k 2.0× 2.1k 0.3× 1.3k 0.2× 438 0.3× 1.6k 1.1× 110 26.3k

Countries citing papers authored by John D. Baxter

Since Specialization
Citations

This map shows the geographic impact of John D. Baxter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John D. Baxter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John D. Baxter more than expected).

Fields of papers citing papers by John D. Baxter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John D. Baxter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John D. Baxter. The network helps show where John D. Baxter may publish in the future.

Co-authorship network of co-authors of John D. Baxter

This figure shows the co-authorship network connecting the top 25 collaborators of John D. Baxter. A scholar is included among the top collaborators of John D. Baxter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John D. Baxter. John D. Baxter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Adams, Jessica, Nimish Patel, Harmanpreet Kaur, et al.. (2020). Comparative effectiveness of antiretroviral drug classes for the treatment of HIV infection in patients with high viral loads: a multicentre retrospective cohort study. HIV Medicine. 22(1). 28–36. 1 indexed citations
4.
Baxter, John D., et al.. (2018). Hepatitis C Virus Reinfection after Sustained Virological Response in Those Who Continue to Inject Drugs at the Time of Treatment. Research Explorer (The University of Manchester). 2 indexed citations
5.
R, Kim & John D. Baxter. (2008). Protease Inhibitor Resistance Update: Where Are We Now?. AIDS Patient Care and STDs. 22(4). 267–277. 21 indexed citations
6.
Kozal, Michael J., Katherine Huppler Hullsiek, Rodger D. MacArthur, et al.. (2007). The Incidence of HIV Drug Resistance and Its Impact on Progression of HIV Disease Among Antiretroviral-Naïve Participants Started on Three Different Antiretroviral Therapy Strategies. HIV Clinical Trials. 8(6). 357–370. 41 indexed citations
7.
Lawrence, Jody, Katherine Huppler Hullsiek, Lisa Thackeray, et al.. (2006). Disadvantages of Structured Treatment Interruption Persist in Patients With Multidrug-Resistant HIV-1. JAIDS Journal of Acquired Immune Deficiency Syndromes. 43(2). 169–178. 17 indexed citations
8.
Baxter, John D.. (2006). New Issues in the Challenge of HIV Drug Resistance. AIDS Patient Care and STDs. 20(11). 737–740. 1 indexed citations
9.
Weatherman, Ross, Ching‐yi Chang, Nicola J. Clegg, et al.. (2002). Ligand-Selective Interactions of ER Detected in Living Cells by Fluorescence Resonance Energy Transfer. Molecular Endocrinology. 16(3). 487–496. 46 indexed citations
10.
Ganeshan, Arul, et al.. (2002). Intravascular lymphoma: a diagnostic enigma. Journal of the Royal Society of Medicine. 95(1). 37–38. 3 indexed citations
11.
Cavalieri, Ralph R., Luiz Alberto Simeoni, John D. Baxter, et al.. (1999). Thyroid Hormone Export in Rat FRTL-5 Thyroid Cells and Mouse NIH-3T3 Cells Is Carrier-Mediated, Verapamil-Sensitive, and Stereospecific1. Endocrinology. 140(11). 4948–4954. 18 indexed citations
12.
Saatcioglu, Fahri, Gabriela N. Lopez, Brian L. West, et al.. (1997). Mutations in the Conserved C-Terminal Sequence in Thyroid Hormone Receptor Dissociate Hormone-Dependent Activation from Interference with AP-1 Activity. Molecular and Cellular Biology. 17(8). 4687–4695. 39 indexed citations
13.
Gardner, David G., et al.. (1988). Processing of the Primary Transcript for the Rat Growth Hormone Gene In Vivo. DNA. 7(8). 537–544. 2 indexed citations
14.
Gutierrez‐Hartmann, Arthur & John D. Baxter. (1987). Differential Ability of Various Plasmid DNAs to Sequester Inhibitors of RNA Polymerase III Transcription. DNA. 6(3). 231–237. 4 indexed citations
15.
Hort, Yvonne, Daniel F. Catanzaro, Judy Tellam, et al.. (1984). Primary Structure of the Human Renin Gene. DNA. 3(6). 457–468. 99 indexed citations
17.
Cathala, Guy, Bernardita Méndez, Brian L. West, et al.. (1983). A Method for Isolation of Intact, Translationally Active Ribonucleic Acid. DNA. 2(4). 329–335. 1396 indexed citations breakdown →
19.
Wegnez, Maurice, Beth S. Schachter, John D. Baxter, & Joseph Martial. (1982). Hormonal Regulation of Growth Hormone mRNA. DNA. 1(2). 145–153. 33 indexed citations
20.
Miller, Walter L., Doris Coit, John D. Baxter, & Joseph Martial. (1981). Cloning of Bovine Prolactin cDNA and Evolutionary Implications of its Sequence. DNA. 1(1). 37–50. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026